ATE181925T1 - Hemmstoffe für kathepsin-g und elastase zur verhütung von bindegewebsabbau - Google Patents

Hemmstoffe für kathepsin-g und elastase zur verhütung von bindegewebsabbau

Info

Publication number
ATE181925T1
ATE181925T1 AT92914209T AT92914209T ATE181925T1 AT E181925 T1 ATE181925 T1 AT E181925T1 AT 92914209 T AT92914209 T AT 92914209T AT 92914209 T AT92914209 T AT 92914209T AT E181925 T1 ATE181925 T1 AT E181925T1
Authority
AT
Austria
Prior art keywords
cathepsin
connective tissue
elastase
inhibitors
tissue degradation
Prior art date
Application number
AT92914209T
Other languages
English (en)
Inventor
Michael R Angelastro
Philippe Bey
Niall S Doherty
Michael J Janusz
Shujaath Mehdi
Norton P Peet
Original Assignee
Merrell Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Pharma Inc filed Critical Merrell Pharma Inc
Application granted granted Critical
Publication of ATE181925T1 publication Critical patent/ATE181925T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0827Tripeptides containing heteroatoms different from O, S, or N
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/021Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)n-C(=0)-, n being 5 or 6; for n > 6, classification in C07K5/06 - C07K5/10, according to the moiety having normal peptide bonds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06191Dipeptides containing heteroatoms different from O, S, or N
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0802Tripeptides with the first amino acid being neutral
    • C07K5/0804Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0806Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02Linear peptides containing at least one abnormal peptide link
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Mobile Radio Communication Systems (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Vehicle Body Suspensions (AREA)
  • Transceivers (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Dental Preparations (AREA)
AT92914209T 1991-05-23 1992-04-21 Hemmstoffe für kathepsin-g und elastase zur verhütung von bindegewebsabbau ATE181925T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US70449991A 1991-05-23 1991-05-23

Publications (1)

Publication Number Publication Date
ATE181925T1 true ATE181925T1 (de) 1999-07-15

Family

ID=24829789

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92914209T ATE181925T1 (de) 1991-05-23 1992-04-21 Hemmstoffe für kathepsin-g und elastase zur verhütung von bindegewebsabbau

Country Status (17)

Country Link
US (1) US5510333A (de)
EP (1) EP0587799B1 (de)
JP (1) JP3442075B2 (de)
AT (1) ATE181925T1 (de)
AU (1) AU655301B2 (de)
DE (1) DE69229552T2 (de)
DK (1) DK0587799T3 (de)
ES (1) ES2136091T3 (de)
FI (1) FI935172A7 (de)
GR (1) GR3031005T3 (de)
HU (1) HU217612B (de)
IL (1) IL101925A (de)
NO (1) NO934218D0 (de)
NZ (1) NZ242807A (de)
PT (1) PT100517B (de)
WO (1) WO1992020357A1 (de)
ZA (1) ZA923602B (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5714470A (en) 1991-08-22 1998-02-03 Merrell Pharmaceuticals, Inc. Orally-active elastase inhibitors
WO1993021221A1 (en) * 1992-04-10 1993-10-28 Abbott Laboratories Pulmonary surfactant protein fragments
JP2668003B2 (ja) * 1992-06-12 1997-10-27 ファイザー インク. ヒトの心臓キマーゼを含むアンギオテンシンiキマーゼに関する阻害剤
HU221310B1 (en) * 1994-06-02 2002-09-28 Merrell Pharma Inc Acylated enol di and tripeptide derivatives, their use and pharmaceutical compositions comprising thereof
HU221311B1 (en) * 1994-06-02 2002-09-28 Merrell Pharma Inc Perfluoroalkyl tripeptides inhibitors of elastase, pharmaceutical compositions comprising thereof and their use
US5804560A (en) * 1995-01-06 1998-09-08 Sibia Neurosciences, Inc. Peptide and peptide analog protease inhibitors
US6017887A (en) * 1995-01-06 2000-01-25 Sibia Neurosciences, Inc. Peptide, peptide analog and amino acid analog protease inhibitors
US5693515A (en) * 1995-04-28 1997-12-02 Arris Pharmaceutical Corporation Metal complexed serine protease inhibitors
DE19543750C2 (de) * 1995-11-24 1997-10-23 Crinos Industria Farmaco Cathepsin G inhibierende Aptamere
US6172044B1 (en) 1995-12-01 2001-01-09 Aventis Pharmaceuticals Inc. Acylated enol derivative of α-ketoesters and α-ketoamides
US5948886A (en) * 1996-11-20 1999-09-07 Hoechst Marion Roussel, Inc. Acylated enol derivatives of α-ketoesters and α-ketoamides
PT912601E (pt) * 1996-04-22 2004-04-30 Massachusetts Inst Technology Supressao da resposta imune via inibicao da catepsina s
JP2002047256A (ja) * 2000-07-26 2002-02-12 Kanegafuchi Chem Ind Co Ltd α−アミノ−α´,α´,α´−トリハロケトン誘導体、α−アミノ−α´,α´,α´−トリハロアルコ−ル誘導体、及び、α−ヒドロキシ−β−アミノカルボン酸誘導体の製造法
WO2008054144A1 (en) * 2006-11-03 2008-05-08 Amorepacific Corporation Skin external composition containing cathepsin g inhibitors for preventing skin aging and the screening method for development of antiaging materials
US8883857B2 (en) 2012-12-07 2014-11-11 Baylor College Of Medicine Small molecule xanthine oxidase inhibitors and methods of use
US20220354833A1 (en) 2019-09-17 2022-11-10 Mereo Biopharma 4 Limited Alvelestat for use in the treatment of graft rejection, bronchiolitis obliterans syndrome and graft versus host disease
DK4106757T3 (da) 2020-04-16 2023-10-23 Mereo Biopharma 4 Ltd Fremgangsmåder der involverer neutrofil elastase-inhibitor alvelestat til behandling af luftvejssygdom medieret af alpha-1-antitrypsin-mangel
AU2021289665A1 (en) 2020-06-10 2022-12-15 Aligos Therapeutics, Inc. Anti-viral compounds for treating coronavirus, picornavirus, and norovirus infections
CA3224494A1 (en) 2021-07-09 2023-01-12 Koen Vandyck Anti-viral compounds
WO2023043816A1 (en) 2021-09-17 2023-03-23 Aligos Therapeutics, Inc. Anti-viral compounds for treating coronavirus, picornavirus, and norovirus infections
CN118265527A (zh) 2021-10-20 2024-06-28 美莱奥生物制药第四有限公司 用于治疗纤维化的中性粒细胞弹性蛋白酶抑制剂
WO2024254398A2 (en) * 2023-06-07 2024-12-12 Redd Pharmaceuticals, Inc. Modulation of neutrophil activation and neutrophil extracellular trap (net) formation

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3230275A1 (de) * 1982-08-14 1984-02-16 Bayer Ag, 5090 Leverkusen Elastaseinhibitoren, verfahren zu ihrer herstellung sowie diese enthaltende arzneimittel
DE3324534A1 (de) * 1983-07-07 1985-01-17 Ciba-Geigy Ag, Basel Modifizierte protease-inhibitoren, verfahren zu ihrer herstellung und daraus bereitete pharmazeutische mittel
US4629724A (en) * 1984-12-03 1986-12-16 E. R. Squibb & Sons, Inc. Amino acid ester and amide renin inhibitors
US4643991A (en) * 1984-12-18 1987-02-17 The University Of Kentucky Research Foundation Peptide elastase inhibitors and methods
GB8600263D0 (en) * 1985-01-22 1986-02-12 Ici America Inc Peptide derivatives
US5055450A (en) * 1985-01-22 1991-10-08 Ici Americas Inc. Peptide derivatives
IL77748A (en) * 1985-02-04 1991-11-21 Merrell Dow Pharma Amino acid and peptide derivatives as peptidase inhibitors
ATE71934T1 (de) * 1985-06-07 1992-02-15 Ici America Inc Selektionierte difluorverbindungen.
GB8613703D0 (en) * 1986-06-05 1986-07-09 Ici America Inc Difluoro peptide compounds
NZ223148A (en) * 1987-01-16 1989-10-27 Merrell Dow Pharma Peptide derivatives having peptidase inhibition activity
EP0307662A3 (de) * 1987-08-24 1990-07-25 Kabushiki Kaisha Vitamin Kenkyusyo Enkephalin-Analoge
EP0356595A1 (de) * 1988-09-01 1990-03-07 Merrell Dow Pharmaceuticals Inc. Peptidase-Hemmer
ZA897514B (en) * 1988-10-07 1990-06-27 Merrell Dow Pharma Novel peptidase inhibitors
ZA905737B (en) * 1989-07-26 1991-05-29 Merrell Dow Pharma Novel peptidase inhibitors
DE3938971A1 (de) * 1989-11-24 1991-05-29 Biotechnolog Forschung Gmbh Leukozytenelastase und kathepsin g blockierendes peptid, dna, vektor, wirtsorganismus und verfahren zu seiner gewinnung sowie pharmazeutisches praeparat

Also Published As

Publication number Publication date
DK0587799T3 (da) 1999-11-22
FI935172L (fi) 1993-11-22
ZA923602B (en) 1993-02-24
EP0587799B1 (de) 1999-07-07
HU9303314D0 (en) 1994-03-28
PT100517A (pt) 1993-09-30
ES2136091T3 (es) 1999-11-16
US5510333A (en) 1996-04-23
EP0587799A4 (de) 1995-06-14
AU2184192A (en) 1992-12-30
EP0587799A1 (de) 1994-03-23
HU217612B (hu) 2000-03-28
IL101925A0 (en) 1992-12-30
IL101925A (en) 1996-03-31
JPH06508355A (ja) 1994-09-22
FI935172A0 (fi) 1993-11-22
PT100517B (pt) 1999-06-30
WO1992020357A1 (en) 1992-11-26
AU655301B2 (en) 1994-12-15
NO934218L (no) 1993-11-22
GR3031005T3 (en) 1999-12-31
NZ242807A (en) 1994-07-26
HUT65140A (en) 1994-04-28
JP3442075B2 (ja) 2003-09-02
NO934218D0 (no) 1993-11-22
DE69229552T2 (de) 1999-12-23
FI935172A7 (fi) 1993-11-22
DE69229552D1 (de) 1999-08-12

Similar Documents

Publication Publication Date Title
ATE181925T1 (de) Hemmstoffe für kathepsin-g und elastase zur verhütung von bindegewebsabbau
ATE193304T1 (de) Inhibitoren der menschlichen neutrophilenelastase
ATE348096T1 (de) C-terminal modifizierte oxamyl dipeptide als inhibitorse von der ice/ced-3 familie von cystein proteasen
ATE416761T1 (de) Prävention und behandlung von durch entzündung ausgelöstem und/oder immunvermitteltem knochenschwund
DE122009000012I1 (de) Substituierte pyrazolyl-benzolsulfonamide zur behandlung von entzundungen.
ES2191102T3 (es) Heterociclos de peptidilo utiles en el tratamiento de las afecciones relacionadas con la trombina.
DK0529568T3 (da) Nye oralt aktive elastaseinhibitorer
DK0705100T3 (da) Terapeutiske substituerede guanidiner
FI943233A7 (fi) Ihmisen Kunitz-tyyppisen proteaasiestäjän muunnos
DK1029921T3 (da) Serpinresistent t-PA, mutanter, gener
BG99177A (bg) Нови 7 бета-заместени-4-аза-5 алфа-холестанони като инхибитори на 5 алфа-редуктаза
FI943232L (fi) Ihmisen Kunitz-tyyppisen proteaasiestäjän muunnos
FI943234A7 (fi) Ihmisen Kunitz-tyyppisen proteaasiestäjän muunnos
FI943231L (fi) Ihmisen Kunitz-tyyppisen proteaasiestäjän muunnoksia
ATE196083T1 (de) Verwendung von ferrioxamin-b zur behandlung septischen schocks
DE69405919D1 (de) Zusammensetzungen zur Behandlung von Keratinfasern
DK0804465T3 (da) Nye elastaseinhibitorer
TR200001026T2 (tr) Nötrofil elastaz inhibitörü olarak pirolopirolon türevleri.
ATE165594T1 (de) Triarylethylenderivate zur therapeutischen verwendung
CA2109516A1 (en) Inhibitors of cathepsin g and elastase for preventing connective tissue degradation
FI972673A7 (fi) 4,4-(disubstituoitu)sykloheksan-1-oli-monomeereja ja vastaavia yhdiste itä

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee